Phase 4 Neuropathy Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University60 enrolled1 locationNCT07558863
Recruiting
Phase 4
Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)
Peripheral NeuropathyMultiple Myeloma, Neoplasms
Tanta University44 enrolled2 locationsNCT07025005
Recruiting
Phase 4
Two Dose Levels of Privigen in Pediatric CIDP
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CSL Behring30 enrolled9 locationsNCT03684018
Recruiting
Phase 4
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Transthyretin Amyloid Polyneuropathy
Qilu Pharmaceutical Co., Ltd.15 enrolled1 locationNCT06940336
Recruiting
Phase 4
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University50 enrolled1 locationNCT06461377
Recruiting
Phase 4
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
University of Aarhus60 enrolled4 locationsNCT04589299